Sort
50,496 grants matching “lung cancer”
NF-kB Regulation of the Muscle Microenvironment in Cancer Cachexia
$401,799Denis C Guttridge · Medical University Of South Carolina · R01 · FY2024 · AR
Exploiting KRAS addiction for lung cancer therapy
$401,777David A Cheresh · University Of California, San Diego · R01 · FY2019 · CA
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$401,744Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2024 · CA
Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies
$401,719Ying Huang · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs
$401,718Michael James Hassett · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Effectiveness of a multilevel integrated intervention for LDCT lung cancer screening and smoking cessation among African Americans
$401,715Tung Sung Tseng · Lsu Health Sciences Center · R01 · FY2024 · MD
Acute radiation injury alters microRNA profiles that predict late tissue-specific damage
$401,703Dorthe Schaue · University Of California Los Angeles · U01 · FY2024 · AI
Acute radiation injury alters microRNA profiles that predict late tissue-specific damage
$401,703Dorthe Schaue · University Of California Los Angeles · U01 · FY2023 · AI
Dissecting the Mechanism of SETDB1 and its K867 Monoubiquitination in Lung Cancer Progression
$401,691Jia Fang · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Unmet needs for specific subsets of EGFR mutated lung cancer
$401,678Daniel Botelho Costa · Beth Israel Deaconess Medical Center · R37 · FY2020 · CA
The Role of PI3-Kinase Signaling Pathway in Defining Sensitivity and Resistance
$401,646Jeffrey A Meyerhardt · Dana-Farber Cancer Inst · P50 · FY2010 · CA
University of Maryland, Baltimore Biomarker Reference Laboratory
$401,644Sanford A Stass · University Of Maryland Baltimore · U24 · FY2012 · CA
Inter-metastatic divergency in small cell lung cancer; implications for the design of future immunotherapies
$401,624Jose R Conejo-Garcia · Duke University · R01 · FY2023 · CA
Prostatitis and Prostate Cancer Development
$401,608Lawrence Fong · University Of California, San Francisco · R01 · FY2014 · CA
Project 1: Murine Modeling of Tumor-Mediated Immunosuppression
$401,513Edgar G. Engleman · Stanford University · U54 · FY2017 · CA
Characterization of the interaction between inflammation and cancer progression
$401,449Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Development and CAD Assessment of a PN Database
$401,429Weill Medical College Of Cornell Univ · U01 · FY2005 · CA
The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma
$401,428Rani E George · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Magnetic Bronchoscope for Improved Pulmonary Access
$401,401Walter Blume · Unandup, Llc · R43 · FY2021 · HL
Erythropoietin Blockade for the Treatment of Cancer
$401,386C. Anthony Blau · University Of Washington · R01 · FY2011 · CA
Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI
$401,317Jeanine M. Genkinger · Columbia University Health Sciences · R01 · FY2016 · CA
Analysis of the Mammalian DNA Damage Response
$401,273Stephen J Elledge · Brigham And Women'S Hospital · R01 · FY2022 · CA
Analysis of the Mammalian DNA Damage Response
$401,273Stephen J Elledge · Brigham And Women'S Hospital · R01 · FY2023 · CA
MOCSLID-CCC
$401,265Donald P Tashkin · University Of California Los Angeles · R01 · FY2009 · HL
Core 1: Biospecimen and Data Management Core
$401,189John B Sunwoo · Stanford University · U54 · FY2019 · CA